Ultralife Revenue, Profits - ULBI Quarterly Income Statement

Add to My Stocks
$9.9 $0.1 (1%) ULBI stock closing price Aug 13, 2018 (Closing)

Financial analysis of Ultralife involves more than just checking the Ultralife stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the ULBI income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of -0.91% when compared to the same period in the past. Along with Ultralife assets and Ultralife free cash flow, Ultralife profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q2 is $1.63M and the 2018 Q2 revenue is $22.86M.

View and download details of revenue and profits for Ultralife for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Ultralife Revenues or Net Sales
22.86M23.07M22.51M21.05M19.94M22.04M21.63M19.63M20.37M20.83M
Cost Of Goods Sold (COGS)16.31M15.78M15.65M14.79M13.71M15.14M14.83M13.63M14.47M14.42M
Ultralife Gross Profit
6.55M7.28M6.88M6.25M6.22M6.88M6.81M5.99M5.9M6.4M
Research & Development Expense1.22M1.1M1.07M1.35M1.18M1.13M1.52M1.35M1.42M1.65M
Selling General & Admin Expense3.7M3.82M3.76M3.63M3.71M3.91M3.66M3.5M3.97M4.26M
Income Before Depreciation Depletion Amortization1.63M2.35M2.05M1.26M1.32M1.84M1.66M1.13M--
Depreciation Depletion Amortization----------
Non Operating Income--0.1M--0.02M-0.01M-0.02M----0.01M
Interest Expense----------
Ultralife Pretax Income
1.72M2.22M2.08M1.2M1.27M1.74M1.65M1.1M--
Provision for Income Taxes---1.71M----0.11M---
MinorityInterest-------0.01M---0.01M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.64M2.15M3.8M1.1M1.09M1.66M1.75M1.02M--
Extraordinary Items & Discontinued Operations----------
Ultralife Profit/ Loss (Net Income)
1.63M2.15M3.8M1.1M1.09M1.66M1.75M1.02M--
Average Shares used to compute Diluted EPS16.52M16.2M16.03M15.97M15.85M15.66M15.36M15.3M15.42M15.67M
Average Shares used to compute Basic EPS15.92M15.7M15.63M15.56M15.51M15.41M15.26M15.21M15.26M15.32M
Income Before Nonrecurring Items1.63M2.15M1.9M1.1M1.09M1.66M1.75M1.02M--
Income from Nonrecurring Items--1.9M-------0.3M
Ultralife Earnings Per Share Basic Net
0.100.140.240.070.070.110.110.070.030.02
Ultralife Earnings Per Share Diluted Net
0.100.130.240.070.070.110.110.070.030.02
EPS Diluted Before Nonrecurring Items0.100.130.120.070.070.110.110.070.030.04
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Ultralife stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Ultralife revenue chart, implies that the company is growing. It has not been the case with Ultralife. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Ultralife try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The ULBI financials along with Ultralife historical stock prices provide a lot of details about the firm.

Ultralife Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
18.33
PS Ratio (price sales ratio)
1.76
Operating Margin
7.1
Net Profit Margin
7.1
Dividend Yield
0%